Comparison of Simoa


Journal

Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278

Informations de publication

Date de publication:
05 2021
Historique:
revised: 08 02 2021
received: 12 11 2020
accepted: 17 03 2021
pubmed: 9 4 2021
medline: 13 1 2022
entrez: 8 4 2021
Statut: ppublish

Résumé

We compared Simoa

Identifiants

pubmed: 33830650
doi: 10.1002/acn3.51355
pmc: PMC8108418
doi:

Substances chimiques

Neurofilament Proteins 0
neurofilament protein L 0

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1141-1150

Informations de copyright

© 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Références

Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
Clin Chem Lab Med. 2016 Oct 1;54(10):1655-61
pubmed: 27071153
Biochem Med (Zagreb). 2011;21(1):49-52
pubmed: 22141206
J Immunol Methods. 2017 Dec;451:1-10
pubmed: 28917434
Bioanalysis. 2019 Aug;11(15):1405-1418
pubmed: 31401845
Ann Neurol. 2017 Jun;81(6):857-870
pubmed: 28512753
J Neuroinflammation. 2019 Dec 23;16(1):272
pubmed: 31870389
Neurology. 2019 Mar 5;92(10):e1007-e1015
pubmed: 30737333
J Clin Chem Clin Biochem. 1983 Nov;21(11):709-20
pubmed: 6655447
Mult Scler. 2012 May;18(5):552-6
pubmed: 22492131

Auteurs

Audrey Gauthier (A)

Paris Sciences et Lettres - École Pratique des Hautes Études, Paris, France.

Sébastien Viel (S)

Immunology laboratory, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.
International Center of Research in Infectiology, Lyon University, INSERM U1111, CNRS UMR 5308, ENS, UCBL, Lyon, France.

Magali Perret (M)

Immunology laboratory, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.

Guillaume Brocard (G)

Université de Lyon, Université Claude Bernard Lyon 1, Lyon, F-69000, France.
Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron, F-69677, France.
Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, Lyon, F-69003, France.
EUGENE DEVIC EDMUS Foundation against multiple sclerosis, state-approved foundation, Bron, F-69677, France.

Romain Casey (R)

Université de Lyon, Université Claude Bernard Lyon 1, Lyon, F-69000, France.
Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron, F-69677, France.
Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, Lyon, F-69003, France.
EUGENE DEVIC EDMUS Foundation against multiple sclerosis, state-approved foundation, Bron, F-69677, France.

Christine Lombard (C)

Immunology laboratory, Hospices Civils de Lyon, Lyon Sud Hospital, Pierre-Bénite, France.

Sabine Laurent-Chabalier (S)

Department of Biostatistics, Clinical Epidemiology, Public Health, and Innovation in Methodology, CHU Nîmes, Univ. Montpellier, Nîmes, France.

Marc Debouverie (M)

Department of Neurology, Nancy University Hospital, Nancy, France.
Université de Lorraine, APEMAC, Nancy, F-54000, France.

Gilles Edan (G)

CHU Pontchaillou, Rennes, CIC1414 INSERM, F-35000, France.

Sandra Vukusic (S)

Université de Lyon, Université Claude Bernard Lyon 1, Lyon, F-69000, France.
Hospices Civils de Lyon, Service de Neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Bron, F-69677, France.
Observatoire Français de la Sclérose en Plaques, Centre de Recherche en Neurosciences de Lyon, INSERM 1028 et CNRS UMR 5292, Lyon, F-69003, France.
EUGENE DEVIC EDMUS Foundation against multiple sclerosis, state-approved foundation, Bron, F-69677, France.

Christine Lebrun-Frénay (C)

Department of Neurology, UR2CA, URRIS, CRCSEP, Centre Hospitalier Universitaire Pasteur2, Université Nice Côte d'Azur, Nice, France.

Jérôme De Sèze (J)

Department of Neurology and Clinical Investigation Center, CIC 1434, INSERM 1434, CHU de Strasbourg, Strasbourg, F-67000, France.

David Axel Laplaud (DA)

Department of Neurology and CIC015 INSERM, CHU de Nantes, Nantes, F-44093, France.
CRTI-Inserm U1064, Nantes, F-44000, France.

Giovanni Castelnovo (G)

Department of Neurology, CHU Nîmes, Univ Montpellier, Nîmes, France.

Olivier Gout (O)

Department of Neurology, Fondation Rothschild, Paris, F-75000, France.

Aurélie Ruet (A)

Univ. Bordeaux, Bordeaux, F-33000, France.
INSERM U1215, Neurocentre Magendie, Bordeaux, F-33000, France.
Department of Neurology, CHU de Bordeaux, CIC Bordeaux CIC1401, Bordeaux, F-33000, France.

Thibault Moreau (T)

Department of Neurology, CHU de Dijon, EA4184, Dijon, F-21000, France.

Olivier Casez (O)

Department of Neurology, CHU Grenoble Alpes, La Tronche/Grenoble, F-38700, France.

Pierre Clavelou (P)

Department of Neurology, CHU Clermont-Ferrand, Clermont-Ferrand, F-63000, France.
Université Clermont Auvergne, Inserm, Neuro-Dol, Clermont-Ferrand, F-63000, France.

Eric Berger (E)

Department of Neurology, CHU Besançon, Besançon, F-25030, France.

Hélène Zephir (H)

CHU Lille, CRCSEP Lille, Univ Lille, Lille, U1172, F-59000, France.

Sophie Trouillet-Assant (S)

International Center of Research in Infectiology, Lyon University, INSERM U1111, CNRS UMR 5308, ENS, UCBL, Lyon, France.
Lyon Sud Hospital, Pierre-Bénite, France.

Eric Thouvenot (E)

Department of Neurology, CHU Nîmes, Univ Montpellier, Nîmes, France.
Institut de Génomique Fonctionnelle, Univ. Montpellier, CNRS, INSERM, Montpellier Cedex 5, F-34094, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH